Portola Pharmaceuticals, Inc. announced the appointment of Sheldon Koenig as executive vice president and chief commercial officer, effective immediately. Mr. Koenig brings to his new role more than three decades of global commercial leadership and operations experience. He will report to Scott Garland, president and chief executive officer, and will serve as a member of the Portola Executive Committee. Prior to joining Portola, Mr. Koenig was senior vice president and head of the cardiovascular franchise for Sanofi where he led U.S. business operations and product launches in more than 20 countries. Previously, he served as vice president and global brand leader for the cardiovascular division of Merck & Co, Inc. where, for more than 25 years, he took on roles of increasing responsibility within the Company’s cardiovascular and thrombosis franchises.